BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1421181)

  • 21. Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting.
    Lazarus HM; Goodnough LT; Goldwasser E; Long G; Arnold JL; Strohl KP
    Bone Marrow Transplant; 1992 Jul; 10(1):71-5. PubMed ID: 1515882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support.
    Bewick M; Conlon M; Gerard S; Lee H; Parissenti AM; Zhang L; Glück S; Lafrenie RM
    Bone Marrow Transplant; 2001 Apr; 27(8):847-53. PubMed ID: 11477443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation.
    Abedi MR; Bäckman L; Boström L; Lindbäck B; Ringdén O
    Bone Marrow Transplant; 1990 Aug; 6(2):121-6. PubMed ID: 2207449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum erythropoietin levels in thalassemia major and intermedia.
    Chaisiripoomkere W; Jootar S; Chanjarunee S; Ungkanont A
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):786-8. PubMed ID: 10928378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
    Mossuz P; Girodon F; Donnard M; Latger-Cannard V; Dobo I; Boiret N; Lecron JC; Binquet C; Barro C; Hermouet S; Praloran V
    Haematologica; 2004 Oct; 89(10):1194-8. PubMed ID: 15477203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression of mutant erythropoietin in hepatocellular carcinoma.
    Funakoshi A; Muta H; Baba T; Shimizu S
    Biochem Biophys Res Commun; 1993 Sep; 195(2):717-22. PubMed ID: 8396923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors.
    Arnold R; Wilke A; Rinke A; Mayer C; Kann PH; Klose KJ; Scherag A; Hahmann M; Müller HH; Barth P
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):820-7. PubMed ID: 18547872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Childhood essential polycythemia: an unusual disorder].
    Straczek H; Lesesve JF; Latger-Cannard V; Bordigoni P
    Ann Biol Clin (Paris); 2005; 63(1):83-7. PubMed ID: 15689316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
    Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
    Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction.
    Ferrario M; Massa M; Rosti V; Campanelli R; Ferlini M; Marinoni B; De Ferrari GM; Meli V; De Amici M; Repetto A; Verri A; Bramucci E; Tavazzi L
    Eur Heart J; 2007 Aug; 28(15):1805-13. PubMed ID: 17412728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression of erythropoietin in hepatocellular carcinoma.
    Muta H; Funakoshi A; Baba T; Uike N; Wakasugi H; Kozuru M; Jimi A
    Intern Med; 1994 Jul; 33(7):427-31. PubMed ID: 7524823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical study of erythropoietin in cerebellar hemangioblastomas associated with secondary polycythemia.
    Tachibana O; Yamashima T; Yamashita J
    Neurosurgery; 1991 Jan; 28(1):24-6. PubMed ID: 1994278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of plasma erythropoietin levels: an early marker of tumor activity.
    Anagnostou A; Chawla MS; Pololi L; Fried W
    Cancer; 1979 Sep; 44(3):1014-6. PubMed ID: 573171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin-dependent erythrocytosis associated with hepatic angiosarcoma.
    Rothmann SA; Savage RA; Paul P
    J Surg Oncol; 1982 Jun; 20(2):105-8. PubMed ID: 6896226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary erythrocytosis due to a cerebellar hemangioblastoma: demonstration of erythropoietin mRNA in the tumor.
    Trimble M; Caro J; Talalla A; Brain M
    Blood; 1991 Aug; 78(3):599-601. PubMed ID: 1859878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Polyvinyl chloride.
    Barr RJ; Bonin M
    JAMA; 1975 Mar; 231(9):914. PubMed ID: 47400
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of liver in erythropoietin production: clinical and experimental evidences.
    Mirand EA; Zucali JR; Murphy GP
    N Y State J Med; 1976 Jul; 76(7):1100-2. PubMed ID: 1064785
    [No Abstract]   [Full Text] [Related]  

  • 38. Polycythemia caused by erythropoietin-producing hemangiosarcoma.
    Imataki O; Uemura M
    EJHaem; 2024 Feb; 5(1):256-257. PubMed ID: 38406540
    [No Abstract]   [Full Text] [Related]  

  • 39. Monitoring hemangioblastoma tumor burden using plasma erythropoietin levels.
    Munt B; Erb S; Humphries K; Shepherd J; Scudamore C; Anderson F; Lam V; Shackleton C; Krystal G
    Int J Hematol; 1992 Oct; 56(2):185-7. PubMed ID: 1421181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors.
    Bardet V; Junior AP; Coste J; Lecoq-Lafon C; Chouzenoux S; Bernard D; Soubrane O; Lacombe C; Calmus Y; Conti F
    Liver Transpl; 2006 Nov; 12(11):1649-54. PubMed ID: 17058250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.